Mpox

Mpox is an exotic infectious disease caused by the Mpox virus. The disease was first identified in laboratory monkeys, thus earning its name, but in its natural state, it seems to infect rodents more than primates. A fever, headache, muscle pains, swollen lymph nodes, and fatigue are the first symptoms in humans. After this, a rash forms with blisters and crusts. Symptoms typically appear 7 to 14 days after exposure. In most cases, symptoms last 2 to 4 weeks. Children, pregnant women, and people with suppressed immune systems are at greater risk of severe cases.

Human Monkeypox – Epidemiology, Clinical Characteristics, Diagnosis, and Prevention

The human monkeypox virus, which belongs to the genus Orthopoxvirus of the family Poxviridae, is a DNA virus.

Monkeypox Epidemiology

What is Monkeypox?

Monkeypox; What is It and How Do We Treat It?

Monkeypox 2003 U.S. Outbreak

Latest Mpox News and Research

Louisiana took months to sound alarm after two babies died in whooping cough outbreak

When there's an outbreak of a vaccine-preventable disease, state health officials typically take certain steps to alert residents and issue public updates about the growing threat.

4 Nov 2025

Lessons from COVID-19 could help communities better prepare for the next pandemic

The COVID-19 pandemic has provided researchers with a wealth of information on contemporary successes and failures in combating an emerging pathogen.

28 Oct 2025

New epimodulation approach improves outbreak forecasts

During an epidemic, some of the most critical questions for healthcare decision-makers are the hardest ones to answer: When will the epidemic peak, how many people will need treatment at once and how long will that peak level of demand for care last? Timely answers can help hospital administrators, community leaders and clinics decide how to deploy staff and other resources most effectively.

24 Oct 2025

WHO launches EIOS 2.0 to accelerate detection and response to public health threats

Today, the World Health Organization (WHO), in collaboration with key partners and supporters, launched version 2.0 of the Epidemic Intelligence from Open Sources (EIOS) system, used globally for the early detection of public health threats.

14 Oct 2025

AI combined with the One Health approach can improve pandemic preparedness

Artificial intelligence could be a valuable tool for detecting emerging diseases earlier, researchers from five European universities and research institutes argue in The Lancet Infectious Diseases.

3 Oct 2025

Global Virus Network accelerates mpox diagnostic research

With global attention shifting away from mpox after recent declines in case counts, the Global Virus Network (GVN) is warning against complacency and urges accelerating efforts to strengthen outbreak readiness.

25 Sep 2025

Rwanda confronts a surprising surge in malaria

After years of progress in reducing malaria cases, Rwanda is confronting a surprising resurgence and signs of treatment resistance that have forced officials to revisit vaccine intervention the country once declined.

15 Sep 2025

Yale scientists boost mRNA vaccine power with new technology

Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their highly effective vaccines to fight the virus.

27 Aug 2025

Novel monoclonal antibodies show promise in preventing severe mpox disease

A team from the Microbiology Department at the Icahn School of Medicine at Mount Sinai has discovered three powerful monoclonal antibodies from a person who had previously been infected with mpox (formerly known as monkeypox).

26 Aug 2025

AI and wastewater surveillance unite to detect emerging viruses

Wastewater surveillance became a popular choice among public health officials looking to track rapid virus mutations and spread patterns during the COVID-19 pandemic.

21 Jul 2025

New WHO guidelines recommend injectable lenacapavir for HIV prevention

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention, in a landmark policy action that could help reshape the global HIV response.

14 Jul 2025

WHO maintains global emergency status for mpox following June 2025 IHR Emergency Committee meeting

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) regarding the upsurge of mpox 2024, held on Thursday, 5 June 2025, from 12:00 to 17:00 CEST.

12 Jul 2025

Blood viral load predicts severity of mpox symptoms

In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.

3 Jul 2025

Monitoring wastewater proves effective in forecasting COVID trends

Published in The Journal of Infectious Diseases, a University of Minnesota research team demonstrated that measuring SARS-CoV-2 in wastewater continues to accurately predict COVID-19 infections in a community.

24 Jun 2025

MPXV virus lingers on hospital surfaces after patient stays

Researchers in the UK found that patients with clade Ib mpox can contaminate their hospital environments with monkeypox virus, including infectious particles. However, the risk of environmental transmission remains unclear and depends on cleaning practices and disease severity.

19 May 2025